Treatment-Resistant Depression Is the Primary Focus
Depression is generally considered treatment-resistant when symptoms persist after at least two antidepressant trials at an adequate dose and duration. Research on ketamine is strongest for this group, so treatment-resistant depression is the main focus of ketamine therapy in Santa Clarita at the practice.
If you have tried several medications through depression treatment and still feel stuck, ketamine may be worth discussing.
Research into ketamine for anxiety, trauma-related symptoms, and mood instability is ongoing, but the evidence is less established than it is for treatment-resistant depression. These uses are off-label and considered case by case.